Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12023427.
- Also identified by PMC identifier 1737920.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 47 year old man is described who developed pathology proven Creutzfeldt-Jakob disease (CJD) 38 years after receiving a low dose of human derived growth hormone (hGH) as part of a diagnostic procedure. The patient presented with a cerebellar syndrome, which is compatible with iatrogenic CJD. This is the longest incubation period described so far for iatrogenic CJD. Furthermore, this is the first report of CJD after diagnostic use of hGH. Since the patient was one of the first in the world to receive hGH, other cases of iatrogenic CJD can be expected in the coming years.
Medical subject headings
- Creutzfeldt-Jakob Syndrome
- Human Growth Hormone